About Universidad de Valladolid - Hospital Universitario Rio Hortega
El Hospital Universitario Río Hortega de Valladolid es el centro hospitalario más moderno de los existentes en la capital vallisoletana. Fue inaugurado por los Príncipes de Asturias Felipe y Letizia el 16 de enero de 2009.
Clinical Trials at Universidad de Valladolid - Hospital Universitario Rio Hortega
During the past decade, Universidad de Valladolid - Hospital Universitario Rio Hortega conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universidad de Valladolid - Hospital Universitario Rio Hortega"
#1 collaborator was "Pharmaceutical Research Associates" with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Universidad de Valladolid - Hospital Universitario Rio Hortega
According to Clinical.Site data, the most researched conditions in "Universidad de Valladolid - Hospital Universitario Rio Hortega" are
"COVID-19" (1 trials), "Coronavirus Infection" (1 trials), "Primary Biliary Cholangitis" (1 trials) and "SARS-CoV2 Infection" (1 trials). Many other conditions were trialed in "Universidad de Valladolid - Hospital Universitario Rio Hortega" in a lesser frequency.
Clinical Trials Intervention Types at Universidad de Valladolid - Hospital Universitario Rio Hortega
Most popular intervention types in "Universidad de Valladolid - Hospital Universitario Rio Hortega" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "EDP-305 1 mg" (1 trials), "EDP-305 2.5 mg" (1 trials) and "Fostamatinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universidad de Valladolid - Hospital Universitario Rio Hortega
The vast majority of trials in "Universidad de Valladolid - Hospital Universitario Rio Hortega" are
2 trials for "All" genders.
Clinical Trials Status at Universidad de Valladolid - Hospital Universitario Rio Hortega
Currently, there are NaN active trials in "Universidad de Valladolid - Hospital Universitario Rio Hortega".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Universidad de Valladolid - Hospital Universitario Rio Hortega,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universidad de Valladolid - Hospital Universitario Rio Hortega, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".